Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Rupprecht

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depressionPeter Zill, Rolf Engel, Thomas C Baghai, et al.
International Journal of Molecular Sciences|June 14, 2018
Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive DisorderThomas C Baghai, Gabriella Varallo-Bedarida, Christoph Born, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 2, 2017
Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC)Frank Padberg, Ulrike Kumpf, Ulrich Mansmann, et al.
Cells|April 9, 2020
Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin FibroblastsKerstin Kuffner, Julian Triebelhorn, Katrin Meindl, et al.
Human Brain Mapping|April 20, 2016
Imbalance in subregional connectivity of the right temporoparietal junction in major depressionTimm B Poeppl, Veronika I Müller, Felix Hoffstaedter, et al.
European Journal of Pharmacology|April 4, 2022
A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregenerationPetra Bloms-Funke, Michael Schumacher, Song Liu, et al.
Translational Psychiatry|September 15, 2019
Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent mannerAnna K Schmidtner, David A Slattery, Joachim Gläsner, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Therapeutic Advances in Psychopharmacology|November 24, 2022
Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humansThomas Vanicek, Murray B Reed, René Seiger, et al.
Psychoneuroendocrinology|December 18, 2020
Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxineLisa-Marie Bahr, Franziska Maurer, Johannes Weigl, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depressionPeter Zill, Rolf Engel, Thomas C Baghai, et al.
International Journal of Molecular Sciences|June 14, 2018
Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive DisorderThomas C Baghai, Gabriella Varallo-Bedarida, Christoph Born, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 2, 2017
Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC)Frank Padberg, Ulrike Kumpf, Ulrich Mansmann, et al.
Cells|April 9, 2020
Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin FibroblastsKerstin Kuffner, Julian Triebelhorn, Katrin Meindl, et al.
Human Brain Mapping|April 20, 2016
Imbalance in subregional connectivity of the right temporoparietal junction in major depressionTimm B Poeppl, Veronika I Müller, Felix Hoffstaedter, et al.
European Journal of Pharmacology|April 4, 2022
A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregenerationPetra Bloms-Funke, Michael Schumacher, Song Liu, et al.
Translational Psychiatry|September 15, 2019
Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent mannerAnna K Schmidtner, David A Slattery, Joachim Gläsner, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Therapeutic Advances in Psychopharmacology|November 24, 2022
Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humansThomas Vanicek, Murray B Reed, René Seiger, et al.
Psychoneuroendocrinology|December 18, 2020
Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxineLisa-Marie Bahr, Franziska Maurer, Johannes Weigl, et al.
Pageof 23